Announcement PDF Appendix 3H - Notification of cessation of securities Announcement Summary Entity name AVECHO BIOTECHNOLOGY LIMITED Announcement Type New announcement Date of this announcement Monday December 02, 2024 Details of +securities that have ceased ASX +security code AVEAS Security description OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES Number of +securities that have ceased 13,977,753 The +securities have ceased due to Date of cessation Lapse of conditional right to securities because the conditions have not been, or have become incapable of being, satisfied 29/11/2024 Refer to next page for full details of the announcement Appendix 3H - Notification of cessation of securities 1/4 Appendix 3H - Notification of cessation of securities Part 1 - Announcement Details 1.1 Name of +Entity AVECHO BIOTECHNOLOGY LIMITED We (the entity named above) provide the following information about our issued capital. 1.2 Registered Number Type Registration Number ACN 056482403 1.3 ASX issuer code AVE 1.4 The announcement is New announcement 1.5 Date of this announcement 2/12/2024 Appendix 3H - Notification of cessation of securities 2/4 Appendix 3H - Notification of cessation of securities Part 2 - Details of +equity securities or +debt securities that have ceased ASX +Security Code and Description AVEAS : OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES Unquoted +equity securities that have ceased Number of securities that have ceased 13,977,753 Reason for cessation Lapse of conditional right to securities because the conditions have not been, or have become incapable of being, satisfied Date of cessation 29/11/2024 Is the entity paying any consideration for the cessation? No Any other information the entity wishes to notify to ASX about the cessation? Lapse and cancellation of options without being exercised. Appendix 3H - Notification of cessation of securities 3/4 Appendix 3H - Notification of cessation of securities Part 3 - Issued capital following changes Following the cessation of the +securities the subject of this notification, the issued capital of the entity will comprise: The figures in parts 3.1 and 3.2 below are automatically generated and may not reflect the entity's current issued capital if other Appendix 2A, Appendix 3G or Appendix 3H forms are currently with ASX for processing. 3.1 Quoted +equity securities and +debt securities (total number of each +class of +securities quoted on ASX) ASX +security code and description Total number of +securities on issue AVE : ORDINARY FULLY PAID 3,169,297,013 AVEOA : OPTION EXPIRING 10-MAY-2026 2,147,130,063 3.2 Unquoted +equity securities (total number of each +class of +equity securities issued but not quoted on ASX) ASX +security code and description AVEAS : OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES Total number of +securities on issue 3,993,644 Note: the figures stated in the tables above are used to calculate the total market capitalisation of the entity published by ASX from time to time. The table will not include those classes of +securities that have ceased or lapsed in their entirety in ASX records before the announcement date described in Q1.5, even if the entity has advised ASX of a change to that class of +security in Part 2 of this form. Appendix 3H - Notification of cessation of securities 4/4